A phase I/II trial of vorinostat (SAHA) in combination with rituximab ‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806

American Journal of Hematology,Volume 93, Issue 4, Page 486-493, April 2018.

Source: American Journal of Hematology - December 20, 2017 Category: Hematology Source Type: research